We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Memphasys is a biotechnology business based in Australia. Memphasys shares (MEM) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Memphasys has a market cap (total outstanding shares value) of $66.5 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Long-term investing
| 52-week range | $0.052 - $0.12 |
|---|---|
| 50-day moving average | $0.0908 |
| 200-day moving average | $0.0714 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.002 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.079
| 1 week (2022-01-10) | -4.82% |
|---|---|
| 1 month (2021-12-17) | -17.71% |
| 3 months (2021-10-18) | 29.51% |
| 6 months (2021-07-16) | 9.72% |
| 1 year (2021-01-18) | -24.76% |
|---|---|
| 2 years (2020-01-17) | 27.42% |
| 3 years (2019-01-17) | 159.02% |
| 5 years (2017-01-17) | -82.15% |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -8.22% |
| Return on equity TTM | -16.19% |
| Profit margin | 0% |
| Book value | 0.011 |
| Market capitalisation | $66.5 million |
TTM: trailing 12 months
We're not expecting Memphasys to pay a dividend over the next 12 months.
Memphasys 's shares were split on a 1:15 basis on 15 August 2018. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Memphasys shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Memphasys shares which in turn could have impacted Memphasys 's share price.
Over the last 12 months, Memphasys 's shares have ranged in value from as little as $0.052 up to $0.12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Memphasys 's is -1.0395. This would suggest that Memphasys 's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Memphasys has bucked the trend.
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix that uses high quality sperm cells from semen samples for human assisted reproductive technologies for treating male factor infertility. The company was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.
Here’s where you can book COVID-19 at-home tests approved for travel and how it works.
We've rounded up everything you need to nail the 'date-worthy' makeup look, including some affordable dupes.
Designed for big companies, this Amex charge card offers a mix of management tools and perks – including a 100,000 bonus Membership Rewards offer.
Rapid antigen tests are proving extremely hard to find, but there are options if you can be patient trying to find a RAT.
We tried the viral Milk Makeup Hydro Grip Primer and spoiler alert, it's the bee's knees.
Drac and the Pack are back, like you’ve never seen them before.
A delightful compact vacuum with an unjustifiable price.
A new player enters the Australian sports broadcast market.
The Amazon Echo Buds 2 are a solid addition to your earholes if you’re already integrated in the Alexa ecosystem. But if you’re not, its hard to find anything here that really stands out.
Bottom meets top in the BBL as Perth look to continue their winning ways against the Strikers.
